Identification of GM1-Ganglioside Secondary Accumulation in Fibroblasts from Neuropathic Gaucher Patients and Effect of a Trivalent Trihydroxypiperidine Iminosugar Compound on Its Storage Reduction

Gaucher disease (GD) is a rare genetic metabolic disorder characterized by a dysfunction of the lysosomal glycoside hydrolase glucocerebrosidase (GCase) due to mutations in the gene GBA1, leading to the cellular accumulation of glucosylceramide (GlcCer). While most of the current research focuses on...

Full description

Bibliographic Details
Published in:	Molecules
Main Authors:	Costanza Ceni, Francesca Clemente, Francesca Mangiavacchi, Camilla Matassini, Rodolfo Tonin, Anna Caciotti, Federica Feo, Domenico Coviello, Amelia Morrone, Francesca Cardona, Martino Calamai
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Subjects:	metabolic disorders lysosome glucocerebrosidase glucosylceramide GM1 flow cytometry
Online Access:	https://www.mdpi.com/1420-3049/29/2/453

Similar Items

A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease
by: Wendy Westbroek, et al.
Published: (2016-07-01)

Enhanced calcium release in the acute neuronopathic form of Gaucher disease
by: Dori Pelled, et al.
Published: (2005-02-01)

Selective Targeting of the Interconversion between Glucosylceramide and Ceramide by Scaffold Tailoring of Iminosugar Inhibitors
by: Cécile Baudoin-Dehoux, et al.
Published: (2019-01-01)

Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis
by: Alexandra Bouscary, et al.
Published: (2019-08-01)

Functional Analysis of Human <i>GBA1</i> Missense Mutations in <i>Drosophila</i>: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences
by: Aparna Kuppuramalingam, et al.
Published: (2024-09-01)

Fluorescent In Situ Staining and Flow Cytometric Procedures as New Pre-Diagnostic Tests for Sialidosis, GM1 Gangliosidosis and Niemann–Pick Type C
by: Claudia Capitini, et al.
Published: (2022-08-01)

The Spectrum of Neurological Manifestations Associated with Gaucher Disease
by: Tamanna Roshan Lal, et al.
Published: (2017-03-01)

Gaucher disease type 2 (case report)
by: D. R. Shagieva, et al.
Published: (2020-09-01)

Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis
by: Francesca Clemente, et al.
Published: (2022-06-01)

Gaucher’s Disease – What Should You Know
by: Dominika Podgórska, et al.
Published: (2024-09-01)

Lysosomal membrane integrity in fibroblasts derived from patients with Gaucher disease
by: Asuka Hamamoto, et al.
Published: (2023-12-01)

Horse-Derived Ceramide Accentuates Glucosylceramide Synthase and Ceramide Synthase 3 by Activating PPARβ/δ and/or PPARγ to Stimulate Ceramide Synthesis
by: Tami Igarashi, et al.
Published: (2023-02-01)

Perinatal-lethal Gaucher disease can be the underlying cause of congenital ichthyosis
by: Kubra Baskin, et al.
Published: (2019-07-01)

The Key Role of GM1 Ganglioside in Parkinson’s Disease
by: Suman Chowdhury, et al.
Published: (2022-01-01)

Neurocognitive profile of adults with the Norrbottnian type of Gaucher disease
by: Panagiota Tsitsi, et al.
Published: (2022-01-01)

Association Between Progranulin and Gaucher Disease
by: Jinlong Jian, et al.
Published: (2016-09-01)

Gaucher disease: achievements and prospects
by: Rodion V. Ponomarev, et al.
Published: (2021-07-01)

Ganglioside GM1 Targets Astrocytes to Stimulate Cerebral Energy Metabolism
by: Charles Finsterwald, et al.
Published: (2021-04-01)

Case Study of a Rare Genetic Disorder: Gaucher Disease
by: A. Xani, et al.
Published: (2025-06-01)

Anti-inflammatory role of GM1 and other gangliosides on microglia
by: Danny Galleguillos, et al.
Published: (2022-01-01)

Dietary gangliosides rescue GM3 synthase deficiency outcomes in mice accompanied by neurogenesis in the hippocampus
by: Jin-ichi Inokuchi, et al.
Published: (2024-07-01)

Mass Spectrometry Evaluation of Biomarkers in the Vitreous Fluid in Gaucher Disease Type 3 with Disease Progression Despite Long-Term Treatment
by: Aizeddin Mhanni, et al.
Published: (2020-01-01)

Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease
by: Yanyan Peng, et al.
Published: (2021-09-01)

Case report: Multidisciplinary collaboration in diagnosis and treatment of child gaucher disease
by: Jianfang Zhu, et al.
Published: (2023-03-01)

Quantification of glucosylceramide in plasma of Gaucher disease patients
by: Maria Viviane Gomes Muller, et al.
Published: (2010-12-01)

Expert consensus guideline on the diagnosis of type 1 Gaucher disease in adult patients
by: Antonio De Vivo, et al.
Published: (2024-06-01)

Glycosphingolipids are linked to elevated neurotransmission and neurodegeneration in a Drosophila model of Niemann Pick type C
by: Anna E. Eberwein, et al.
Published: (2023-10-01)

Isolation and Structure Elucidation of GM4-Type Gangliosides from the Okinawan Starfish Protoreaster nodosus
by: Tomofumi Miyamoto, et al.
Published: (2012-11-01)

The Missing Link - Likely Pathogenetic Role of GM3 and Other Gangliosides in the Development of Diabetic Nephropathy
by: Igor Vukovic, et al.
Published: (2015-05-01)

Type 1 and Type 3 Gaucher Disease in Two Siblings in A Family: 2 Unusual Case Reports
by: DOLANCHAMPA MODAK, et al.
Published: (2015-02-01)

Synthesis of “<i>All-Cis”</i> Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors
by: Maria Giulia Davighi, et al.
Published: (2020-10-01)

The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects
by: Yoo-Mi Kim, et al.
Published: (2020-11-01)

The Role of Lipid Environment in Ganglioside GM1-Induced Amyloid β Aggregation
by: Vladimir Rudajev, et al.
Published: (2020-09-01)

A novel mutation deep within intron 7 of the GBA gene causes Gaucher disease
by: Anna Malekkou, et al.
Published: (2020-03-01)

Une déformation du fémur en flacon d'Erlenmeyer: la maladie de Gaucher
by: Faten Frikha, et al.
Published: (2015-04-01)

Rapid and long‐lasting efficacy of high‐dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review
by: Kanako Higashi, et al.
Published: (2024-04-01)

A natural history study of pediatric patients with early onset of GM1 gangliosidosis, GM2 gangliosidoses, or gaucher disease type 2 (RETRIEVE)
by: Bénédicte Héron, et al.
Published: (2024-12-01)

Characterization of the genotypes of patients with Gaucher disease type 1 in the Russian Federation
by: K A Lukina, et al.
Published: (2013-07-01)

CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson’s disease
by: Rui Wang, et al.
Published: (2023-05-01)

<i>N</i>-Alkylated Iminosugar Based Ligands: Synthesis and Inhibition of Human Lysosomal β-Glucocerebrosidase
by: Andreas Wolfsgruber, et al.
Published: (2020-10-01)